Concepedia

Publication | Open Access

Economic Impact of Treating Invasive Mold Disease with Isavuconazole Compared with Liposomal Amphotericin B in the UK

DOIFull Paper Access

16

Citations

24

References

2018

Year

Emma Bagshaw, David Enoch, M. Blackney, Jan Posthumus, Daniel Kuessner
Future Microbiology

Abstract

ISAV has the potential to reduce IMD treatment costs relative to L-AMB followed by POSA.

References

YearCitations

Page 1